Replies to post #8265 on Generex Biotechnology Corp. (fka GNBTQ)

[JNdouble1]

Your point is understood.

The substantial equivalency pathway can be very fuzzy, especially if your predicate is very old technology.

The clearance involved here helps to legitimize the company, but I will agree in part, that it isn't the end of the story regarding GNBT.